Néji Tebib

1.1k total citations
66 papers, 537 citations indexed

About

Néji Tebib is a scholar working on Molecular Biology, Physiology and Clinical Biochemistry. According to data from OpenAlex, Néji Tebib has authored 66 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 25 papers in Physiology and 18 papers in Clinical Biochemistry. Recurrent topics in Néji Tebib's work include Lysosomal Storage Disorders Research (21 papers), Metabolism and Genetic Disorders (18 papers) and Carbohydrate Chemistry and Synthesis (12 papers). Néji Tebib is often cited by papers focused on Lysosomal Storage Disorders Research (21 papers), Metabolism and Genetic Disorders (18 papers) and Carbohydrate Chemistry and Synthesis (12 papers). Néji Tebib collaborates with scholars based in Tunisia, France and Saudi Arabia. Néji Tebib's co-authors include Hatem Azzouz, Amel Ben Chehida, Hadhami Ben Turkia, Sonia Abdelhak, Naziha Kaabachi, Jalel Chemli, Khadija Boussetta, S. Barsaoui, M Chaâbouni and Kamel Monastiri and has published in prestigious journals such as Journal of Hepatology, Gene and Archives of Disease in Childhood.

In The Last Decade

Néji Tebib

62 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Néji Tebib Tunisia 14 164 164 112 89 89 66 537
Walla Al‐Hertani Canada 13 159 1.0× 142 0.9× 105 0.9× 126 1.4× 48 0.5× 36 597
Hatem Azzouz Tunisia 11 97 0.6× 102 0.6× 50 0.4× 53 0.6× 61 0.7× 39 392
S. B. van der Meer Netherlands 14 207 1.3× 58 0.4× 91 0.8× 202 2.3× 76 0.9× 19 564
G. Hammersen Germany 12 218 1.3× 76 0.5× 106 0.9× 217 2.4× 55 0.6× 27 565
Nancy Leslie United States 14 318 1.9× 188 1.1× 47 0.4× 402 4.5× 87 1.0× 24 681
Kandiah Umapathysivam Australia 12 121 0.7× 217 1.3× 146 1.3× 27 0.3× 115 1.3× 30 562
Sara Reiss United States 13 126 0.8× 180 1.1× 34 0.3× 51 0.6× 14 0.2× 19 510
Ashish O. Gupta United States 13 180 1.1× 78 0.5× 50 0.4× 64 0.7× 13 0.1× 77 473
Anna Liberek Poland 13 79 0.5× 173 1.1× 57 0.5× 7 0.1× 68 0.8× 61 512
Y Matoth Israel 17 155 0.9× 243 1.5× 67 0.6× 20 0.2× 85 1.0× 42 693

Countries citing papers authored by Néji Tebib

Since Specialization
Citations

This map shows the geographic impact of Néji Tebib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Néji Tebib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Néji Tebib more than expected).

Fields of papers citing papers by Néji Tebib

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Néji Tebib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Néji Tebib. The network helps show where Néji Tebib may publish in the future.

Co-authorship network of co-authors of Néji Tebib

This figure shows the co-authorship network connecting the top 25 collaborators of Néji Tebib. A scholar is included among the top collaborators of Néji Tebib based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Néji Tebib. Néji Tebib is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mabrouk, Sameh, Hadhami Ben Turkia, Salima Ferchichi, et al.. (2022). Molecular characterization of CTNS mutations in Tunisian patients with ocular cystinosis. Diagnostic Pathology. 17(1). 44–44. 1 indexed citations
2.
Chehida, Amel Ben, Ichraf Kraoua, Haïfa Sanhaji, et al.. (2020). Non-ketotic hyperglycinaemia: a frequent, but poorly diagnosed and managed genetic disorder in Tunisia. Archives of Disease in Childhood. 106(3). 311–311. 1 indexed citations
3.
Chehida, Amel Ben, Lilia Kraoua, Heather Etchevers, et al.. (2019). A severe clinical phenotype of Noonan syndrome with neonatal hypertrophic cardiomyopathy in the second case worldwide withRAF1S259Y neomutation. Genetics Research. 101. e6–e6. 3 indexed citations
4.
Kremer, Laura S., Pierre Lesimple, Martine Gilleron, et al.. (2016). Severe respiratory complex III defect prevents liver adaptation to prolonged fasting. Journal of Hepatology. 65(2). 377–385. 19 indexed citations
5.
Aloulou, Hajer, Syrine Gallas, I. Chabchoub, et al.. (2016). Clinical and Genetic Characterization of 26 Tunisian Patients with Allgrove Syndrome. Archives of Medical Research. 47(2). 105–110. 19 indexed citations
6.
7.
Chehida, Amel Ben, et al.. (2015). A novel homozygous missense mutation in the insulin receptor gene results in an atypical presentation of Rabson-Mendenhall syndrome. European Journal of Medical Genetics. 59(1). 16–19. 10 indexed citations
8.
Chehida, Amel Ben, Hatem Azzouz, Sonia Abdelhak, et al.. (2015). Complications rénales dans la glycogénose de type 1 : quelles implications pratiques ?. Néphrologie & Thérapeutique. 11(4). 240–245. 1 indexed citations
9.
Azzouz, Hatem, François Petit, Mariem Ben Khelifa, et al.. (2013). Molecular and biochemical characterization of a novel intronic single point mutation in a Tunisian family with glycogen storage disease type III. Molecular Biology Reports. 40(7). 4197–4202. 7 indexed citations
10.
Bouyacoub, Yosra, Hatem Azzouz, Mariem Ben Rekaya, et al.. (2013). Novel and recurrent mutations in the TAT gene in Tunisian families affected with Richner–Hanhart Syndrome. Gene. 529(1). 45–49. 8 indexed citations
11.
Azzouz, Hatem, et al.. (2012). Screening of three Mediterranean phenylketonuria mutations in Tunisian families. Journal of Genetics. 91(1). 91–94. 4 indexed citations
12.
Turkia, Hadhami Ben, Jalel Chemli, Olga Amaral, et al.. (2012). Diagnostic moléculaire de la maladie de Gaucher en Tunisie. Pathologie Biologie. 61(2). 59–63. 3 indexed citations
13.
Mili, A., Ilhem Ben Charfeddine, Ons Mamaï, et al.. (2011). Molecular and biochemical characterization of Tunisian patients with glycogen storage disease type III. Journal of Human Genetics. 57(3). 170–175. 20 indexed citations
14.
Turkia, Hadhami Ben, et al.. (2009). Phenotypic continuum of type 2 Gaucher's disease: an intermediate phenotype between perinatal-lethal and classic type 2 Gaucher's disease. Journal of Perinatology. 29(2). 170–172. 12 indexed citations
15.
Chaâbouni, M, Maher Kharrat, Lilia Kraoua, et al.. (2009). A novel UBE3A truncating mutation in large Tunisian Angelman syndrome pedigree. American Journal of Medical Genetics Part A. 152A(1). 141–146. 18 indexed citations
16.
Turkia, Hadhami Ben, et al.. (2009). Cholestase néonatale révélatrice d’un phénotype intermédiaire d’une maladie de Gaucher type 2. Archives de Pédiatrie. 16(3). 255–257. 6 indexed citations
17.
Turkia, Hadhami Ben, et al.. (2008). Lipodystrophie congénitale généralisée de type 1 avec atteinte neurologique. Archives de Pédiatrie. 16(1). 27–31. 8 indexed citations
18.
Turkia, Hadhami Ben, et al.. (2008). Présentation atypique de la maladie de Wegener de l’enfant. Journal des Maladies Vasculaires. 33(4-5). 242–246.
19.
Turkia, Hadhami Ben, Néji Tebib, Olga Amaral, et al.. (2007). [Mutation spectrum of Gaucher disease in Tunisia: high frequency of N370S/Rec NciI compound heterozygous].. PubMed. 84(1-4). 65–70. 5 indexed citations
20.
Monastiri, Kamel, M. Mokni, Michaël Nilges, et al.. (2006). Clinical and mutational investigations of tyrosinemia type II in Northern Tunisia: Identification and structural characterization of two novel TAT mutations. Molecular Genetics and Metabolism. 88(2). 184–191. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026